Literature DB >> 22434220

Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice.

Sarah Dubreucq1, Isabelle Matias, Pierre Cardinal, Martin Häring, Beat Lutz, Giovanni Marsicano, Francis Chaouloff.   

Abstract

The endocannabinoid system (ECS) tightly controls emotional responses to acute aversive stimuli. Repeated stress alters ECS activity but the role played by the ECS in the emotional consequences of repeated stress has not been investigated in detail. This study used social defeat stress, together with pharmacology and genetics to examine the role of cannabinoid type-1 (CB(1)) receptors on repeated stress-induced emotional alterations. Seven daily social defeat sessions increased water (but not food) intake, sucrose preference, anxiety, cued fear expression, and adrenal weight in C57BL/6N mice. The first and the last social stress sessions triggered immediate brain region-dependent changes in the concentrations of the principal endocannabinoids anandamide and 2-arachidonoylglycerol. Pretreatment before each of the seven stress sessions with the CB(1) receptor antagonist rimonabant prolonged freezing responses of stressed mice during cued fear recall tests. Repeated social stress abolished the increased fear expression displayed by constitutive CB(1) receptor-deficient mice. The use of mutant mice lacking CB(1) receptors from cortical glutamatergic neurons or from GABAergic neurons indicated that it is the absence of the former CB(1) receptor population that is responsible for the fear responses in socially stressed CB(1) mutant mice. In addition, stress-induced hypolocomotor reactivity was amplified by the absence of CB(1) receptors from GABAergic neurons. Mutant mice lacking CB(1) receptors from serotonergic neurons displayed a higher anxiety but decreased cued fear expression than their wild-type controls. These mutant mice failed to show social stress-elicited increased sucrose preference. This study shows that (i) release of endocannabinoids during stress exposure impedes stress-elicited amplification of cued fear behavior, (ii) social stress opposes the increased fear expression and delayed between-session extinction because of the absence of CB(1) receptors from cortical glutamatergic neurons, and (iii) CB(1) receptors on central serotonergic neurons are involved in the sweet consumption response to repeated stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434220      PMCID: PMC3376321          DOI: 10.1038/npp.2012.36

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  97 in total

Review 1.  The molecular logic of endocannabinoid signalling.

Authors:  Daniele Piomelli
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

2.  Glucocorticoids dose-dependently remodel energy stores and amplify incentive relativity effects.

Authors:  Norman Pecoraro; Francisca Gomez; Mary F Dallman
Journal:  Psychoneuroendocrinology       Date:  2005-10       Impact factor: 4.905

3.  Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice.

Authors:  Alicia Izquierdo; Cara L Wellman; Andrew Holmes
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

4.  Exposure to a stressor produces a long lasting enhancement of fear learning in rats.

Authors:  Vinuta Rau; Michael S Fanselow
Journal:  Stress       Date:  2009-03       Impact factor: 3.493

Review 5.  Endocannabinoids and retrograde modulation of synaptic transmission.

Authors:  Takako Ohno-Shosaku; Asami Tanimura; Yuki Hashimotodani; Masanobu Kano
Journal:  Neuroscientist       Date:  2011-04-29       Impact factor: 7.519

6.  Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress.

Authors:  Tatyana Strekalova; Natalia Gorenkova; Edward Schunk; Oleg Dolgov; Dusan Bartsch
Journal:  Behav Pharmacol       Date:  2006-05       Impact factor: 2.293

7.  Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling.

Authors:  Sachin Patel; Craig T Roelke; David J Rademacher; Cecilia J Hillard
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

8.  Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin.

Authors:  C Becker; B Zeau; C Rivat; A Blugeot; M Hamon; J-J Benoliel
Journal:  Mol Psychiatry       Date:  2007-09-25       Impact factor: 15.992

9.  Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.

Authors:  Marco Bortolato; Regina A Mangieri; Jin Fu; Janet H Kim; Oliver Arguello; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Daniele Piomelli
Journal:  Biol Psychiatry       Date:  2007-05-23       Impact factor: 13.382

10.  Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.

Authors:  M A Steiner; K Wanisch; K Monory; G Marsicano; E Borroni; H Bächli; F Holsboer; B Lutz; C T Wotjak
Journal:  Pharmacogenomics J       Date:  2007-08-07       Impact factor: 3.550

View more
  52 in total

1.  Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis.

Authors:  Christelle Glangetas; Delphine Girard; Laurent Groc; Giovanni Marsicano; Francis Chaouloff; François Georges
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

Review 2.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

Review 3.  Social stress models in depression research: what do they tell us?

Authors:  Francis Chaouloff
Journal:  Cell Tissue Res       Date:  2013-03-27       Impact factor: 5.249

4.  Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade.

Authors:  Luigi Bellocchio; Edgar Soria-Gómez; Carmelo Quarta; Mathilde Metna-Laurent; Pierre Cardinal; Elke Binder; Astrid Cannich; Anna Delamarre; Martin Häring; Mar Martín-Fontecha; David Vega; Thierry Leste-Lasserre; Dusan Bartsch; Krisztina Monory; Beat Lutz; Francis Chaouloff; Uberto Pagotto; Manuel Guzman; Daniela Cota; Giovanni Marsicano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

Review 5.  Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications.

Authors:  Yvonne M Ulrich-Lai; Karen K Ryan
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

6.  Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.

Authors:  Rachel J Donahue; John W Muschamp; Scott J Russo; Eric J Nestler; William A Carlezon
Journal:  Biol Psychiatry       Date:  2014-01-08       Impact factor: 13.382

Review 7.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

8.  Endocannabinoid Signaling in the Stress Response of Male and Female Songbirds.

Authors:  Molly J Dickens; Haley A Vecchiarelli; Matthew N Hill; George E Bentley
Journal:  Endocrinology       Date:  2015-10-02       Impact factor: 4.736

9.  Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.

Authors:  Elena Martín-García; Lucie Bourgoin; Adeline Cathala; Fernando Kasanetz; Miguel Mondesir; Ana Gutiérrez-Rodriguez; Leire Reguero; Jean-François Fiancette; Pedro Grandes; Umberto Spampinato; Rafael Maldonado; Pier Vincenzo Piazza; Giovanni Marsicano; Véronique Deroche-Gamonet
Journal:  Neuropsychopharmacology       Date:  2015-11-27       Impact factor: 7.853

10.  Self-medication with sucrose.

Authors:  Yvonne M Ulrich-Lai
Journal:  Curr Opin Behav Sci       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.